Welcome to our Q1 2023 Quarterly Report. For this edition, we have selected a couple of topics that we believe would be of interest to our clients and partners. We also share Bryan Garnier’s partners views on the M&A activity within their sectors of expertise, including healthcare, software, industrial tech, energy transition & sustainability, and digital media.
The topics we cover:
- Gender bias in healthcare: in the healthcare industry, medical research primarily focuses on males, leading to disproportionate health improvements favoring men. Women’s health is often neglected, with female-specific therapeutics/devices developed based on insufficient evidence. We discuss this issue and how it strengthens investors’ concerns for the lack of exits and consolidation.
- US Inflation Reduction Act: we outline the US Inflation Reduction Act’s impact on Europe’s industrial policy. This act has implications for climate, trade, security, and foreign policy, and the EU is taking measures to become a green powerhouse, with an investment plan – InvestEU – forecasting at least €1 trillion in public and private investment.
- M&A deals activity: our partners share their M&A market views and the investment banking team’s latest transactions in healthcare, software, industrial tech, energy transition and sustainability, and digital media.
We hope these insights provide valuable information for investors interested in staying on top of the latest market trends.
We invite you to download the report for more valuable insights. Please contact us at communication@bryangarnier.com for any inquiries.
Read the full report here
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.